| DNTH |
Dianthus Therapeutics, Inc. /DE/ |
03 Feb 2026 |
1 |
$0 |
4 |
SVP, General Counsel and Sec. |
04 Feb 2026, 17:41 |
| DNTH |
Dianthus Therapeutics, Inc. /DE/ |
03 Feb 2025 |
1 |
$0 |
4 |
SVP, General Counsel and Sec. |
04 Feb 2025, 16:23 |
| DNTH |
Dianthus Therapeutics, Inc. /DE/ |
23 May 2024 |
1 |
$0 |
4 |
SVP, General Counsel and Sec. |
28 May 2024, 20:05 |
| DNTH |
Dianthus Therapeutics, Inc. /DE/ |
24 Jan 2024 |
1 |
$0 |
4 |
SVP, General Counsel and Sec. |
26 Jan 2024, 16:46 |
| DNTH |
Dianthus Therapeutics, Inc. /DE/ |
11 Sep 2023 |
0 |
$0 |
3 |
SVP, GENERAL COUNSEL & SECRETARY Exhibit 24 - Power of Attorney |
13 Sep 2023, 20:48 |
| /report/000120919123007500-veness-adam-m-2023-02-03 |
Cyteir Therapeutics, Inc. |
03 Feb 2023 |
1 |
$0 |
4 |
General Counsel |
07 Feb 2023, 15:14 |
| /report/000120919122027079-veness-adam-m-2022-05-02 |
Cyteir Therapeutics, Inc. |
02 May 2022 |
1 |
$0 |
4 |
General Counsel |
04 May 2022, 16:22 |
| /report/000120919122027073-veness-adam-m-2022-04-25 |
Cyteir Therapeutics, Inc. |
25 Apr 2022 |
0 |
$0 |
3 |
General Counsel |
04 May 2022, 16:15 |
| /report/000110465921142271-veness-adam-m-2021-11-19 |
ACCELERON PHARMA INC |
19 Nov 2021 |
6 |
$0 |
4 |
SVP, General Counsel and Sec. |
22 Nov 2021, 08:05 |
| /report/000117911021010095-veness-adam-m-2021-11-09 |
ACCELERON PHARMA INC |
09 Nov 2021 |
2 |
+$132,165 |
4 |
SVP, General Counsel and Sec. |
12 Nov 2021, 15:15 |
| /report/000117911021008895-veness-adam-m-2021-09-21 |
ACCELERON PHARMA INC |
21 Sep 2021 |
5 |
-$781,208 |
4 |
SVP, General Counsel and Sec. |
22 Sep 2021, 18:08 |
| /report/000117911021008690-veness-adam-m-2021-09-07 |
ACCELERON PHARMA INC |
07 Sep 2021 |
3 |
-$259,624 |
4 |
SVP, General Counsel and Sec. |
09 Sep 2021, 17:07 |
| /report/000117911021006496-veness-adam-m-2021-06-07 |
ACCELERON PHARMA INC |
07 Jun 2021 |
1 |
-$13,683 |
4 |
SVP, General Counsel and Sec. |
08 Jun 2021, 18:53 |